Bangladesh vs Egypt: Share of people with HIV who receive antiretroviral therapy
Bangladesh
41.0%
in 2024
Egypt
45.0%
in 2024
Bangladesh rank
131st
Egypt rank
129th
Share of people with HIV who receive antiretroviral therapy over time
- Bangladesh
- Egypt
How they compare
Egypt currently reports 45.0% against 41.0% in Bangladesh, a difference of 4.0%.
That makes Egypt's figure about 1.1 times Bangladesh's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Egypt ahead.
Bangladesh ranks 131st and Egypt ranks 129th of 143 countries.
Across the 3 decades both report, Bangladesh averaged higher in 2 and Egypt in 1.
Head to head by decade
| Decade | Bangladesh | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 0.6% | 0.5% | Bangladesh |
| 2010s | 14.1% | 9.9% | 4.2% | Bangladesh |
| 2020s | 34.2% | 34.4% | 0.2% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Bangladesh or Egypt?
- Egypt, at 45.0% against 41.0% in Bangladesh as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Bangladesh and Egypt?
- 4.0%, with Egypt ahead.
- How many years of comparable data are there for Bangladesh and Egypt?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Egypt rank globally for share of people with hiv who receive antiretroviral therapy?
- Bangladesh ranks 131st and Egypt ranks 129th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.